Kristin T. Killingberg
Trondheim, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Erratum to 'Evaluation of Radiation Therapy Treatment Plans in a Randomized Phase 2 Trial Comparing 2 Schedules of Twice-Daily Thoracic Radiation Therapy in Limited Stage Small Cell Lung Cancer.' International Journal of Radiation Oncology*Biology*Physics, Volume 120, Issue 2, 1 October 2024, Pages 332-342.
Journal: International journal of radiation oncology, biology, physics
Published: April 03, 2026
Subtyping limited stage small cell lung cancer (LS SCLC) reveals inflammatory subtypes with improved chemoradiotherapy outcomes.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 16, 2026
Changes in use of radiotherapy for lung cancer - A Norwegian population-based study from 2000 until 2020.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 16, 2025
Associations between progastrin-releasing peptide (ProGRP) and neuron-specific enolase (NSE) and survival in patients with limited-stage small cell lung cancer (LS SCLC) receiving chemoradiotherapy (CRT).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 12, 2025
High-Dose Versus Standard-Dose Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC: Final Survival Data, Long-Term Toxicity, and Relapse Patterns in a Randomized, Open-Label, Phase II Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: February 14, 2025
Associations Between Patient-Reported Nutritional Status, Toxicity, and Survival in Limited-Stage SCLC.
Journal: JTO clinical and research reports
Published: May 08, 2024
Effect of FDG PET-CT for Staging and Radiotherapy Planning - A Comparison of Cohorts From Two Randomized Trials of Thoracic Radiotherapy in Limited-Stage SCLC.
Journal: JTO clinical and research reports
Published: January 15, 2024
Evaluation of Radiation Therapy Treatment Plans in a Randomized Phase 2 Trial Comparing 2 Schedules of Twice-Daily Thoracic Radiation Therapy in Limited Stage Small Cell Lung Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: November 30, 2023
Treatment Outcomes of Older Participants in a Randomized Trial Comparing Two Schedules of Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 08, 2022
Associations between Measured and Patient-Reported Physical Function and Survival in Advanced NSCLC.
Associations between Measured and Patient-Reported Physical Function and Survival in Advanced NSCLC.
Journal: Healthcare (Basel, Switzerland)
Published: April 10, 2022
Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 03, 2022
Prognostic Value of Post First-Line Chemotherapy Glasgow Prognostic Score in Advanced Non-Small Cell Lung Cancer.
Journal: Clinical Medicine Insights. Oncology
Published: October 21, 2021
Last Updated: 09/26/2026